2018 International Congress » Parkinson's Disease: Psychiatric Manifestations

Date: Monday, October 8, 2018

Time: 1:15pm-2:45pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:15pm-2:45pm: Acoustic analysis and subjective vocal perception of Parkinson’s disease patients and healthy control and the relation to depression and quality of life

Y. Manor, S. Naor, D. Shpunt, N. Diamant, N. Zivion, L. Hayat, A. Yaron, A. Hillel, A. Ezra, I. Opher, Y. Hauptman, R. Aloni-Lavi, A. Faust-Socher, T. Gurevich (Tel Aviv, Israel)

1:15pm-2:45pm: Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the raphe nuclei

T. Barber, L. Griffanti, K. Muhammed, D. Drew, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, M. Husain, M. Hu, J. Klein (Oxford, United Kingdom)

1:15pm-2:45pm: Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study

Y. Xing, S. Naidu, S. Schwarz, N. Bajaj, D. Auer (Nottingham, United Kingdom)

1:15pm-2:45pm: Categorising visual hallucinations in early Parkinson’s disease

B. Clegg, G. Duncan, T. Khoo, R. Barker, D. Burn, A. Yarnall, R. Lawson (Newcastle upon Tyne, United Kingdom)

1:15pm-2:45pm: Correlation between mood and behavioral disorders and quality of life in patients with Parkinson’s disease

O. Galceava, A. Mita, L. Giurgiulescu, R. Latea, V. Tudorica, D. Gheonea, D. Stanca (Craiova, Romania)

1:15pm-2:45pm: Depression (BDI-II) in Parkinson’s disease: Prevalence, types, and variables associated to major, minor and subclinical depression in COPPADIS cohort

M. Aguilar, P. Pastor, M. Almeria, I. Alvarez, S. Arribas, I. Gonzalez, M. Sierra, J. Infante, A. Avila, M. Catalan, F. Alonso, C. Villanueva, L. Lopez, V. Nogueira, V. Puente, A. Crespo, J. Garcia, F. Damas, E. Pacheco, P. Martínez-Martin, D. Santos, G. Coppadis (Terrassa, Spain)

1:15pm-2:45pm: Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

J. Zhu, L. Zhang (Nanjing, China)

1:15pm-2:45pm: Depression, apathy, fatigue in Parkinson with or without STN DBS

L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)

1:15pm-2:45pm: Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy

Y. Shen, J. Li, Y. Yuan, X. Wang, M. Wang, J. Wang, H. Zhang, L. Zhu, K. Zhang (Nanjing, China)

1:15pm-2:45pm: Dissociate effect of dopaminergic therapy in reward expectation and prediction error in PD patients with comorbid impulse control disorder

JF. Martin-Rodriguez, A. Rodriguez-Baena, L. Garrote Espina, P. Alvarez Toledo, S. Jesus, C. Mendez Barrio, A. Adarmes Gomez, F. Carrillo Garcia, M. Carballo Cordero, P. Mir (Seville, Spain)

1:15pm-2:45pm: Erotophonophilia and severe impulse control disorder in a patient with Parkinson’s disease

C. vander Linden, H. Colle, D. Colle, J. Jankovic (Ghent, Belgium)

1:15pm-2:45pm: Evaluation of affective temperament and bipolarity among patients with Parkinson’ s disease

Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)

1:15pm-2:45pm: Evaluation of impulsivity in Parkinson’ s disease

Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)

1:15pm-2:45pm: Evaluation of Parkinson’s Disease Psychosis Requires Structured Questioning of Patients and Caregivers

P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, C. Andersson, S. Andes, D. Fredericks, A. Shim (Miami, FL, USA)

1:15pm-2:45pm: Examining Parkinson’s disease psychosis treatment outcomes in the real world: The insyte observational study

J. Goldman, D. Fredericks, C. Heywood, A. Ryan, A. Shim (Chicago, IL, USA)

1:15pm-2:45pm: Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson’s disease

S. Li, R. Ou, X. Yuan, H. Liu, Y. Bing, Q. Wei, W. Song, B. Cao, Y. Chen, H. Shang (Chengdu, China)

1:15pm-2:45pm: Identifying delirium and it prevalence in idiopathic Parkinson’s disease

R. Lawson, C. McDonald, D. Burn (Newcastle upon Tyne, United Kingdom)

1:15pm-2:45pm: Impaired performance on measures of goal-directed behavior are associated with greater caregiver burden in Parkinson’s disease

N. Dahodwala, C. McMillan, C. Nwadiogbu, J. Liu, A. Miller, M. Pavon, D. Weintraub, L. Massimo (Philadelphia, PA, USA)

1:15pm-2:45pm: Impulsive-Compulsive Behaviour disorders: A longitudinal study in de-novo in Parkinson’s disease patients

L. Ricciardi, C. Lambert, M. Edwards, F. Morgante (London, United Kingdom)

1:15pm-2:45pm: Intercultural differences in the frequency of impulsive control disorders in Parkinson’s disease

J. Martinez Castrillo, C. Lastras Fernandez-Escandon, I. Domingez Zabaleta, C. Estevez Fraga, G. Sanchez Diez, A. Alonso Canovas (Madrid, Spain)

1:15pm-2:45pm: Measuring salivary cortisol levels in persons with Parkinson’s disease (PD)

A. Hiller, B. Lobb, J. Proulx, J. Quinn (Portland, OR, USA)

1:15pm-2:45pm: Neuropathological correlates of psychiatric disorders in PD

J. Hinkle, N. Fischer, K. Perepezko, C. Bakker, M. Broen, A. Butala, T. Dawson, A. Leentjens, Z. Mari, C. Marvel, K. Mills, E. Moukheiber, A. Pantelyat, O. Pletniková, L. Rosenthal, M. Shepard, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Neuropsychiatric disorders in observed patients with Parkinson’s disease

S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)

1:15pm-2:45pm: Parkinson’s disease anxiety is associated with Lewy bodies in the Anterior Cingulate

N. Fischer, J. Hinkle, K. Perepezko, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Patient Experience of Parkinson’s Disease Psychosis Management

P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, A. Shim, D. Fredericks (Miami, FL, USA)

1:15pm-2:45pm: Patients with Parkinson’s disease and psychosis have altered structural connectivity of the executive and visual networks

P. Pal, A. Lenka, M. Ingalhalikar, A. Shah, J. Saini, S. Arumugham, S. Hegde, L. George, R. Yadav (Bangalore, India)

1:15pm-2:45pm: Patterns of Long-Term Custodial Care in Parkinson Disease Psychosis

J. Wetmore, H. Yan, M. Irfan, A. Shim, Y. Peng, D. Gilbertson, S. Li (Minneapolis, MN, USA)

1:15pm-2:45pm: Personality Traits and Sleep Quality in Parkinson’s disease patients

JY. Yun, HJ. Kim, HN. Kim, HL. Kim (Seoul, Republic of Korea)

1:15pm-2:45pm: Pimavanserin Combined With Anti-Dementia Medications for Parkinson Disease Psychosis

A. Espay, M. Guskey, N. Larsen, B. Coate, J. Vizcarra, S. Factor, J. Friedman, D. Weintraub, A. Lang (Cincinnati, OH, USA)

1:15pm-2:45pm: Prevalence and associations for depression in patients with Parkinson’s disease: A Sri Lankan experience

T. Herath, C. Rodrigo, M. Withana (Colombo, Sri Lanka)

1:15pm-2:45pm: Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson’s disease

J. Zhu, L. Zhang (Nanjing, China)

1:15pm-2:45pm: Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease

M. Şenol, M. Kendirli (Istanbul, Turkey)

1:15pm-2:45pm: Rasagiline as Adjunctive Therapy Induced Impulse Control Disorders in Parkinson’s Disease

M. Şenol, M. Kendirli (Istanbul, Turkey)

1:15pm-2:45pm: Suicide attempts, suicidal and death ideation in Parkinson’s disease

MM. Dumitru, A. Papari (Iasi, Romania)

1:15pm-2:45pm: Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic

L. Williams, B. Magennis, N. Feerick, T. Lynch (Dublin, Ireland)

1:15pm-2:45pm: What can we learn from fMRI capture of visual hallucinations in Parkinson’s disease?

K. Dujardin, D. Roman, G. Baille, D. Pins, S. Lefebvre, C. Delmaire, L. Defebvre, R. Jardri (Lille, France)